Epiduo 0.3 %/2.5 % gel
Authorisation PA25691/005/002 · Galderma S.A. the Netherlands Branch
- Licence holder
- Galderma S.A. the Netherlands Branch (all products →)
- Active substances
- Adapalene, Anhydrous Benzoyl Peroxide
- Clinical trials
- 2 clinical trials →
- Dosage form
- Gel
- Route of administration
- Cutaneous use
- ATC code
- D10AD53
- First authorised
- 14/10/2022
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Fixed combination application (Article 10b of Directive No 2001/83/EC)
Adapalene: supply and approvals
9 authorised products on the HPRA list contain Adapalene. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Anhydrous Benzoyl Peroxide: supply and approvals
3 authorised products on the HPRA list contain Anhydrous Benzoyl Peroxide. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 4 years (since 14 October 2022). The HPRA list marks it as not marketed: it is licensed but the holder has not reported it as on sale.
Other medicines with Adapalene in Ireland
8 other products on the HPRA list contain Adapalene, from 4 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Differin 0.1% w/w Gel | Galderma International | National authorisation (PA) | Marketed |
| Epiduo 0.1%/2.5% gel | Galderma S.A. the Netherlands Branch | National authorisation (PA) | Marketed |
| Differin 0.1% w/w Cream | Galderma International | National authorisation (PA) | Not marketed |
| Differin 0.1% w/w Cream | PCO Manufacturing Ltd. | Parallel import (PPA) | Not stated |
| Differin 0.1% w/w cream | IMED Healthcare Ltd., | Parallel import (PPA) | Not stated |
| Differin 0.1% w/w gel | PCO Manufacturing Ltd. | Parallel import (PPA) | Not stated |
| Differin 0.1% w/w gel | IMED Healthcare Ltd., | Parallel import (PPA) | Not stated |
| Epiduo 0.1%/2.5% gel | PCO Manufacturing Ltd. | Parallel import (PPA) | Not stated |
Other medicines with Anhydrous Benzoyl Peroxide in Ireland
2 other products on the HPRA list contain Anhydrous Benzoyl Peroxide, from 2 licence holders; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Clindamycin + Benzoyl Peroxide 10 mg/g + 50 mg/g gel | Aspire Pharma (Malta) Limited | National authorisation (PA) | Not marketed |
| Duac Once Daily 10 mg/g + 50 mg/g gel | PCO Manufacturing Ltd. | Parallel import (PPA) | Not stated |
The licence holder
Galderma S.A. the Netherlands Branch holds 7 products on the HPRA list, with 8 different active substances; 4 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.